|
 |
< Return
|
|
Results from search for: “emslie”
1 items found:
- Graham J. Emslie, M.D., Professor and Chair, Division of Child and Adolescent Psychiatry, University of Texas Southwestern Medical Center and Director, Bob Smith Center for Research in Pediatric Psychiatry, Dallas, TX. Consultant and member of speakers bureaus for Bristol-Myers Squibb, Eli Lilly, McNeil, Otsuka, and Wyeth-Ayerst. Receives grant/research support from Novartis. (Preliminary Report of the Task Force on SSRIs and Suicidal Behavior in Youth, American College of Neuropsychopharmacology, 1/21/04, p.16; on file with CSPI) Consultant to GlaxoSmithKline, Forest, and Pfizer. Receives research support from Eli Lilly, Organon, RepliGen, and Wyeth-Ayerst. Member of the speakers bureau for McNeil. ("Experience in the use of SSRIs and other antidepressants in children and teens"; conference disclosure notes: Child & Adolescent Psychiatry, convened by The College of Physicians and Surgeons of Columbia University, April 2003, Washington, DC. On file at CSPI) Serves on the Corporate Contributions and Research Committee for the American Academy of Child and Adolescent Psychiatry. (http://www3.utsouthwestern.edu/psychiatry/facbios/emslie.htm; accessed 6/16/03)
|
|
| |
CLICK HERE FOR NON-PROFIT ORGANIZATIONS AND UNIVERSITIES WITH TIES TO INDUSTRY.
Users are urged to independently verify all information. The accuracy of the list cannot be guaranteed because we cannot independently verify all citations. However, we only use usually reliable sources.
Listings do not generally include connections to non-profit entities. The reader should consider the listed information as a complement to other information.
Some information came from undated documents or résumés. In such cases, entries list the date CSPI received that information. Whenever available, we have disclosed the specific amount of funding.
We welcome any corrections as well as additional relevant information.
Tell us what you think about the Integrity in Science database.
|
|
|
